chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 19.0
Sex: M
Vaccine: SMALL, SMALL, SMALL, SMALL, ANTH, SMALL
Symptoms: Chest pain, Dyspnoea, Headache, Injection site pain, Injection site swelling
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 418495. A 19-year-old male patient received the following vaccination on 26 February 2011: ACAM2000, lot number 8204003A (lot number invalid). NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. On 08 March 2011, ten days after receiving the vaccine, the patient developed worsening chest pain and was subsequently hospitalized (admission date not reported). An electrocardiogram revealed diffuse ST segment elevation. Laboratory results showed increased Troponin I (2.77) and elevated cardiac enzymes in acute MI range. The patient was diagnosed with acute myopericarditis. The patient had no current illness and no past medical history. Outcome was reported as unknown. Documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: SMALL, SMALL, SMALL, SMALL, ANTH, SMALL
Symptoms: Cardiac function test, Chest discomfort, Echocardiogram, Ejection fraction decreased, Pleuritic pain
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 418495. A 19-year-old male patient received the following vaccination on 26 February 2011: ACAM2000, lot number 8204003A (lot number invalid). NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. On 08 March 2011, ten days after receiving the vaccine, the patient developed worsening chest pain and was subsequently hospitalized (admission date not reported). An electrocardiogram revealed diffuse ST segment elevation. Laboratory results showed increased Troponin I (2.77) and elevated cardiac enzymes in acute MI range. The patient was diagnosed with acute myopericarditis. The patient had no current illness and no past medical history. Outcome was reported as unknown. Documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: SMALL, SMALL, SMALL, SMALL, ANTH, SMALL
Symptoms: Troponin increased
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 418495. A 19-year-old male patient received the following vaccination on 26 February 2011: ACAM2000, lot number 8204003A (lot number invalid). NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. On 08 March 2011, ten days after receiving the vaccine, the patient developed worsening chest pain and was subsequently hospitalized (admission date not reported). An electrocardiogram revealed diffuse ST segment elevation. Laboratory results showed increased Troponin I (2.77) and elevated cardiac enzymes in acute MI range. The patient was diagnosed with acute myopericarditis. The patient had no current illness and no past medical history. Outcome was reported as unknown. Documents held by sender: None.
Age: 19.0
Sex: M
Vaccine: SMALL, SMALL, SMALL, SMALL, ANTH, SMALL
Symptoms: Echocardiogram abnormal, Electrocardiogram abnormal, Pericardial disease, Pericarditis, Troponin I increased
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 418495. A 19-year-old male patient received the following vaccination on 26 February 2011: ACAM2000, lot number 8204003A (lot number invalid). NOTE: Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. On 08 March 2011, ten days after receiving the vaccine, the patient developed worsening chest pain and was subsequently hospitalized (admission date not reported). An electrocardiogram revealed diffuse ST segment elevation. Laboratory results showed increased Troponin I (2.77) and elevated cardiac enzymes in acute MI range. The patient was diagnosed with acute myopericarditis. The patient had no current illness and no past medical history. Outcome was reported as unknown. Documents held by sender: None.
Age: 28.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Arthralgia, Chest pain, Dyspnoea, Echocardiogram abnormal, Ejection fraction decreased
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419029. A 28-year-old male patient received the following vaccinations on 02 March 2011: a right arm ACAM2000 (lot number VV04003A), and a left arm intramuscular (dose 2) injection of BIOTHRAX (Emergent, lot number FAV275). The patient had no current illnesses, took no other medications and no medical history. On 13 March 2011, the patient developed myalgia, arthralgia, a fever of 102.2 Fahrenheit (F), chest pain and shortness of breath. The patient required an Emergency visit and was hospitalized. An echocardiogram was performed and showed an ejection fraction (EF) 40% with global ventricular dysfunction (myopericarditis). The outcome was reported as recovered. Documents held by sender: None.
Age: 28.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL
Symptoms: Myalgia, Myopericarditis, Pyrexia, Ventricular dysfunction
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419029. A 28-year-old male patient received the following vaccinations on 02 March 2011: a right arm ACAM2000 (lot number VV04003A), and a left arm intramuscular (dose 2) injection of BIOTHRAX (Emergent, lot number FAV275). The patient had no current illnesses, took no other medications and no medical history. On 13 March 2011, the patient developed myalgia, arthralgia, a fever of 102.2 Fahrenheit (F), chest pain and shortness of breath. The patient required an Emergency visit and was hospitalized. An echocardiogram was performed and showed an ejection fraction (EF) 40% with global ventricular dysfunction (myopericarditis). The outcome was reported as recovered. Documents held by sender: None.
Age: 21.0
Sex: F
Vaccine: ANTH, FLUN3, HEP, HEPA, SMALL, TYP, ANTH, FLUN3, HEP, HEPA, SMALL, TYP
Symptoms: Induration, Injection site pruritus, Injection site swelling, Keloid scar, Papule
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419030. A 21-year-old female patient experienced a keloid scar after receiving the following vaccinations on 09 October 2009: ACAM2000 (right arm), TYPHIM VI (left arm), BIOTHRAX (left arm), hepatitis A (other manufacturer, left arm) hepatitis B (other manufacturer, left arm) and FLUMIST. Lot numbers were not reported. The patient had a history of sickle cell trait, ASCUS (atypical squamous cells of undetermined significance), chlamydia, migraine, and PFS; allergies included amoxicillin (rash) and a history of "blacking out" after taking TYLENOL. The patient stated that the smallpox vaccine site followed the usual 3-4 week evolution following immunization, but that the site "looked like a bubble" once the skin had healed on 09 November 2009. On 14 March 2011, 17 months post-vaccination, the patient presented to a healthcare center with complaints of ongoing concerns regarding the appearance of the vaccination site, noting that it "doesn't look normal", and that it "still itches and looks like a bubble". On exam she was noted to have a raised, non-tender, hyperpigmented, round, fibrous papule measuring approximately 1.3 cm x 1 cm in diameter with a firm center. The papule was not fluid or pus-filled, and no erythema or warmth was noted. Per the examiner, it appeared to be consistent with a keloid and the patient was referred to dermatology for possibly biopsy and removal. The event subsequently resolved on an unspecified date.
Age: 21.0
Sex: F
Vaccine: ANTH, FLUN3, HEP, HEPA, SMALL, TYP, ANTH, FLUN3, HEP, HEPA, SMALL, TYP
Symptoms: Skin hyperpigmentation
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419030. A 21-year-old female patient experienced a keloid scar after receiving the following vaccinations on 09 October 2009: ACAM2000 (right arm), TYPHIM VI (left arm), BIOTHRAX (left arm), hepatitis A (other manufacturer, left arm) hepatitis B (other manufacturer, left arm) and FLUMIST. Lot numbers were not reported. The patient had a history of sickle cell trait, ASCUS (atypical squamous cells of undetermined significance), chlamydia, migraine, and PFS; allergies included amoxicillin (rash) and a history of "blacking out" after taking TYLENOL. The patient stated that the smallpox vaccine site followed the usual 3-4 week evolution following immunization, but that the site "looked like a bubble" once the skin had healed on 09 November 2009. On 14 March 2011, 17 months post-vaccination, the patient presented to a healthcare center with complaints of ongoing concerns regarding the appearance of the vaccination site, noting that it "doesn't look normal", and that it "still itches and looks like a bubble". On exam she was noted to have a raised, non-tender, hyperpigmented, round, fibrous papule measuring approximately 1.3 cm x 1 cm in diameter with a firm center. The papule was not fluid or pus-filled, and no erythema or warmth was noted. Per the examiner, it appeared to be consistent with a keloid and the patient was referred to dermatology for possibly biopsy and removal. The event subsequently resolved on an unspecified date.
Age: 21.0
Sex: F
Vaccine: ANTH, FLUN3, HEP, HEPA, SMALL, TYP, ANTH, FLUN3, HEP, HEPA, SMALL, TYP
Symptoms: Injection site discolouration, Injection site induration, Injection site papule, Injection site pruritus, Injection site reaction
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419030. A 21-year-old female patient experienced a keloid scar after receiving the following vaccinations on 09 October 2009: ACAM2000 (right arm), TYPHIM VI (left arm), BIOTHRAX (left arm), hepatitis A (other manufacturer, left arm) hepatitis B (other manufacturer, left arm) and FLUMIST. Lot numbers were not reported. The patient had a history of sickle cell trait, ASCUS (atypical squamous cells of undetermined significance), chlamydia, migraine, and PFS; allergies included amoxicillin (rash) and a history of "blacking out" after taking TYLENOL. The patient stated that the smallpox vaccine site followed the usual 3-4 week evolution following immunization, but that the site "looked like a bubble" once the skin had healed on 09 November 2009. On 14 March 2011, 17 months post-vaccination, the patient presented to a healthcare center with complaints of ongoing concerns regarding the appearance of the vaccination site, noting that it "doesn't look normal", and that it "still itches and looks like a bubble". On exam she was noted to have a raised, non-tender, hyperpigmented, round, fibrous papule measuring approximately 1.3 cm x 1 cm in diameter with a firm center. The papule was not fluid or pus-filled, and no erythema or warmth was noted. Per the examiner, it appeared to be consistent with a keloid and the patient was referred to dermatology for possibly biopsy and removal. The event subsequently resolved on an unspecified date.
Age: 21.0
Sex: F
Vaccine: ANTH, FLUN3, HEP, HEPA, SMALL, TYP, ANTH, FLUN3, HEP, HEPA, SMALL, TYP
Symptoms: Injection site swelling, Injection site vesicles, Keloid scar
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419030. A 21-year-old female patient experienced a keloid scar after receiving the following vaccinations on 09 October 2009: ACAM2000 (right arm), TYPHIM VI (left arm), BIOTHRAX (left arm), hepatitis A (other manufacturer, left arm) hepatitis B (other manufacturer, left arm) and FLUMIST. Lot numbers were not reported. The patient had a history of sickle cell trait, ASCUS (atypical squamous cells of undetermined significance), chlamydia, migraine, and PFS; allergies included amoxicillin (rash) and a history of "blacking out" after taking TYLENOL. The patient stated that the smallpox vaccine site followed the usual 3-4 week evolution following immunization, but that the site "looked like a bubble" once the skin had healed on 09 November 2009. On 14 March 2011, 17 months post-vaccination, the patient presented to a healthcare center with complaints of ongoing concerns regarding the appearance of the vaccination site, noting that it "doesn't look normal", and that it "still itches and looks like a bubble". On exam she was noted to have a raised, non-tender, hyperpigmented, round, fibrous papule measuring approximately 1.3 cm x 1 cm in diameter with a firm center. The papule was not fluid or pus-filled, and no erythema or warmth was noted. Per the examiner, it appeared to be consistent with a keloid and the patient was referred to dermatology for possibly biopsy and removal. The event subsequently resolved on an unspecified date.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Rash pustular, Urticaria, Vasculitis
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419184. A 21-year-old male patient received the following vaccinations on 25 February 2011: ACAM2000 (lot number VV04003A) and BIOTHRAX (Emergent, lot number EAV263). The patient had no current illnesses, no medical history and was taking no other medications. On 08 March 2011, the patient developed diffuse urticarial reaction over the bilateral upper extremities, not including the palms. There was no involvement of trunk. The bilateral lower extremity involvement with urticaria and pustule formation was on the thighs. The bilateral lower extremity involvement with urticaria and pustule information was on the thighs. The confluent vasculitis was over the calves. The patient required an Emergency visit. The outcome was reported as unknown. Documents held by sender: None.
Age: 21.0
Sex: M
Vaccine: ANTH, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Pallor, Rash, Rash pustular, Urticaria
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419184. A 21-year-old male patient received the following vaccinations on 25 February 2011: ACAM2000 (lot number VV04003A) and BIOTHRAX (Emergent, lot number EAV263). The patient had no current illnesses, no medical history and was taking no other medications. On 08 March 2011, the patient developed diffuse urticarial reaction over the bilateral upper extremities, not including the palms. There was no involvement of trunk. The bilateral lower extremity involvement with urticaria and pustule formation was on the thighs. The bilateral lower extremity involvement with urticaria and pustule information was on the thighs. The confluent vasculitis was over the calves. The patient required an Emergency visit. The outcome was reported as unknown. Documents held by sender: None.
Age: 1.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Exposure to vaccinated person
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419200. A 1.3-year-old female, whose father had received ACAM2000 (lot not reported) on 08 March 2011, was found chewing on a used bandage on 19 March 2011. On 21 March 2011, the patient's mother noted a "pimple-like reaction" above the left eyebrow. The patient was seen in the emergency department. No other symptoms were noted, and outcome was not reported.
Age: 1.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Acne, Exposure to vaccinated person
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419200. A 1.3-year-old female, whose father had received ACAM2000 (lot not reported) on 08 March 2011, was found chewing on a used bandage on 19 March 2011. On 21 March 2011, the patient's mother noted a "pimple-like reaction" above the left eyebrow. The patient was seen in the emergency department. No other symptoms were noted, and outcome was not reported.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Erythema, Erythema multiforme, Rash pruritic, Skin lesion
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419276. A 20-year-old male patient received the following vaccinations on 22 February 2011: ACAM2000 (lot number VV04003A), TYPHIM VI (lot number E0302), BIOTHRAX (Emergent, lot number FAV261). The patient had no medical history and no illness at the time of vaccination. The patient had no concurrent illnesses and took no other medications. He had a history of a Purified Protein Derivative (PPD) test in the past. On 01 March 2011, one week after the patient received the smallpox, anthrax and typhoid vaccines, he developed red "target" lesions on hands, genitalia and buttocks. Three weeks after the vaccines the rash was gone from the genitalia and improving on hands and buttocks. The rash was itchy and appeared to be erythema multiforme. The outcome was reported as unknown. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Erythema multiforme, Genital rash, Rash erythematous, Rash pruritic, Skin lesion
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419276. A 20-year-old male patient received the following vaccinations on 22 February 2011: ACAM2000 (lot number VV04003A), TYPHIM VI (lot number E0302), BIOTHRAX (Emergent, lot number FAV261). The patient had no medical history and no illness at the time of vaccination. The patient had no concurrent illnesses and took no other medications. He had a history of a Purified Protein Derivative (PPD) test in the past. On 01 March 2011, one week after the patient received the smallpox, anthrax and typhoid vaccines, he developed red "target" lesions on hands, genitalia and buttocks. Three weeks after the vaccines the rash was gone from the genitalia and improving on hands and buttocks. The rash was itchy and appeared to be erythema multiforme. The outcome was reported as unknown. Documents held by sender: None.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest pain, Dyspnoea, Echocardiogram abnormal, Ejection fraction, Electrocardiogram normal
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419355. A 20 year-old male patient had received a left arm injection of ACAM2000 (lot number VV04003A) on 08 March 2011 and 10 days later on 18 March 2011, experienced exertional chest pain and dyspnea during a physical fitness test. He was diagnosed with myocarditis. His Troponins were "drastically" elevated. He was evaluated in the emergency room and hospitalized for five days (dates not provided). Laboratory tests included Troponin I which peaked at 14, normal EKG and abnormal echocardiogram which showed preserved LVEF. The patient's current illnesses and history were reported as none. The event was considered life threatening. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Myocarditis, Troponin I increased
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419355. A 20 year-old male patient had received a left arm injection of ACAM2000 (lot number VV04003A) on 08 March 2011 and 10 days later on 18 March 2011, experienced exertional chest pain and dyspnea during a physical fitness test. He was diagnosed with myocarditis. His Troponins were "drastically" elevated. He was evaluated in the emergency room and hospitalized for five days (dates not provided). Laboratory tests included Troponin I which peaked at 14, normal EKG and abnormal echocardiogram which showed preserved LVEF. The patient's current illnesses and history were reported as none. The event was considered life threatening. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chest pain, Dyspnoea exertional, Echocardiogram abnormal, Ejection fraction, Electrocardiogram normal
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419355. A 20 year-old male patient had received a left arm injection of ACAM2000 (lot number VV04003A) on 08 March 2011 and 10 days later on 18 March 2011, experienced exertional chest pain and dyspnea during a physical fitness test. He was diagnosed with myocarditis. His Troponins were "drastically" elevated. He was evaluated in the emergency room and hospitalized for five days (dates not provided). Laboratory tests included Troponin I which peaked at 14, normal EKG and abnormal echocardiogram which showed preserved LVEF. The patient's current illnesses and history were reported as none. The event was considered life threatening. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Papule, Rash morbilliform, Rash pustular, Respiratory disorder
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419356. A 20 year-old male patient had received on 08 March 2011 a left arm injection of ACAM2000 (lot number VV04003A), and 10 days later on 18 March 2011 presented with a scattered morbilliform rash consisting of erythematous pustules and papules scattered diffusely across arms, trunk and legs. The rash was nonpruritic, nontender and no lesions were noted on the face. The patient also had mild upper respiratory symptoms. The physician presumed the diagnosis to be non-viral pustulosis. The lesions subsided over the course of two to three days without treatment. Lab data, current illnesses and history were none. Other medications and prior vaccinations were not reported. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Erythema, Rash, Rash morbilliform, Rash papular, Rash pustular
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419356. A 20 year-old male patient had received on 08 March 2011 a left arm injection of ACAM2000 (lot number VV04003A), and 10 days later on 18 March 2011 presented with a scattered morbilliform rash consisting of erythematous pustules and papules scattered diffusely across arms, trunk and legs. The rash was nonpruritic, nontender and no lesions were noted on the face. The patient also had mild upper respiratory symptoms. The physician presumed the diagnosis to be non-viral pustulosis. The lesions subsided over the course of two to three days without treatment. Lab data, current illnesses and history were none. Other medications and prior vaccinations were not reported. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Age: 20.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Respiratory disorder
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419356. A 20 year-old male patient had received on 08 March 2011 a left arm injection of ACAM2000 (lot number VV04003A), and 10 days later on 18 March 2011 presented with a scattered morbilliform rash consisting of erythematous pustules and papules scattered diffusely across arms, trunk and legs. The rash was nonpruritic, nontender and no lesions were noted on the face. The patient also had mild upper respiratory symptoms. The physician presumed the diagnosis to be non-viral pustulosis. The lesions subsided over the course of two to three days without treatment. Lab data, current illnesses and history were none. Other medications and prior vaccinations were not reported. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Age: 28.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Blood creatine phosphokinase MB, C-reactive protein, Chest pain, Electrocardiogram abnormal, Full blood count
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419447. A 28 year-old male patient had received a left arm injection of ACAM2000 (lot number VV04003A) on 09 March 2011 and six days later on 15 March 2011, had been experiencing for two consecutive days in the evening sharp chest pain. His EKG (electrocardiogram) was abnormal indicating sinus bradycardia. Additional laboratory tests included: CBC, ESR, BMP, Troponin I/T, "Ultrasensitivite" CRP and CK-MB. He was evaluated in the emergency room. The patient has a history of DM, acne, gout, hyperlipidemia and SAR. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Age: 28.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Metabolic function test, Red blood cell sedimentation rate, Sinus bradycardia, Troponin I, Troponin T
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419447. A 28 year-old male patient had received a left arm injection of ACAM2000 (lot number VV04003A) on 09 March 2011 and six days later on 15 March 2011, had been experiencing for two consecutive days in the evening sharp chest pain. His EKG (electrocardiogram) was abnormal indicating sinus bradycardia. Additional laboratory tests included: CBC, ESR, BMP, Troponin I/T, "Ultrasensitivite" CRP and CK-MB. He was evaluated in the emergency room. The patient has a history of DM, acne, gout, hyperlipidemia and SAR. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Age: 25.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chills, Full blood count normal, Hyperhidrosis, Laboratory test normal, Oropharyngeal pain
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419529. A 25 year-old male patient had received on 09 March 2011 a left arm injection of ACAM2000 (lot number VV04003A), and 14 days later on 23 March 2011 experienced sweating night chills, sore throat and small lesions on back, chest and head. Lab data included a CBC - Normal and a Chem Panel - Normal. Concomitant medications included SEPTRA. Current illnesses and history were reported as none. Prior vaccinations were not reported. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Age: 25.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Skin lesion
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419529. A 25 year-old male patient had received on 09 March 2011 a left arm injection of ACAM2000 (lot number VV04003A), and 14 days later on 23 March 2011 experienced sweating night chills, sore throat and small lesions on back, chest and head. Lab data included a CBC - Normal and a Chem Panel - Normal. Concomitant medications included SEPTRA. Current illnesses and history were reported as none. Prior vaccinations were not reported. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Age: 25.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Chills, Full blood count normal, Laboratory test normal, Night sweats, Oropharyngeal pain
Clinical narrative: This case was received on 24 May 2011 via a third party query tool search on the VAERS database, under reference number 419529. A 25 year-old male patient had received on 09 March 2011 a left arm injection of ACAM2000 (lot number VV04003A), and 14 days later on 23 March 2011 experienced sweating night chills, sore throat and small lesions on back, chest and head. Lab data included a CBC - Normal and a Chem Panel - Normal. Concomitant medications included SEPTRA. Current illnesses and history were reported as none. Prior vaccinations were not reported. No further information was available at the time of the report. The patient's outcome was recovered. Documents held by sender: none.
Age: 22.0
Sex: M
Vaccine: SMALL, ANTH, SMALL
Symptoms: Echocardiogram normal, Electrocardiogram abnormal, Myocarditis, Troponin I increased
Clinical narrative: This study case was received from the investigator (MILVAX) in a trial on 29 March 2011. A 22 year-old male subject with no significant medical history was found to have non-specific myocarditis 20 days after he received an injection of ACAM2000 (lot number, route and site of administration not reported) and ANTHRAX 1 (manufacturer name, lot number, route and site of administration not reported) on 07 August 2010. Relevant laboratory data included: an abnormal Troponin I with the highest recorded value of 04.76, an abnormal electrocardiogram (ECG), and a normal Echocardiogram. Lumbar puncture and MRI of brain, spinal cord, and heart were not performed. Treatments were not reported. The subject's outcome was not reported. Additional information will be requested from the investigator. Note: There is no reporter causality assessment as this is a safety surveillance (data mining, non-interventional) study. Follow-up information was received 23 June 2011 via a third party query tool search on the VAERS database. New information consisted of VAERS ID number 420209. Documents held by sender: none.
Age: 29.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Post vaccination autoinoculation
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 420477. A 29-year-old male patient received the following vaccination on 29 March 2011: ACAM2000 (lot number VV04003A). The patient's medical history and concomitant medications were not reported. On 06 April 2011, the patient had developed post vaccination autoinoculation with self inoculation of approximately 50% "TBS" (total body surface) which required an Emergency Visit. The outcome was reported as unknown. Documents held by sender: None.
Age: 20.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Erythema, Papule, Thrombotic thrombocytopenic purpura, Treponema test negative
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 420651. A 20-year-old female patient with no concurrent illnesses, no medical history, and no use of other medications, had received the following vaccination on 27 January 2011: ACAM2000 (lot number not reported, site unknown), and 10 days later developed bilateral hand, elbow and knee with several 1-2 mm coalescing erythematosus papules with (+) ITP (idiopathic thrombocytopenic purpura, coded by VAERS as: thrombotic thrombocytopenic purpura). It was not mentioned if treatment was required. The patient recovered (date not reported). Documents held by sender: None.
Age: 20.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Erythema, Idiopathic thrombocytopenic purpura, Papule
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 420651. A 20-year-old female patient with no concurrent illnesses, no medical history, and no use of other medications, had received the following vaccination on 27 January 2011: ACAM2000 (lot number not reported, site unknown), and 10 days later developed bilateral hand, elbow and knee with several 1-2 mm coalescing erythematosus papules with (+) ITP (idiopathic thrombocytopenic purpura, coded by VAERS as: thrombotic thrombocytopenic purpura). It was not mentioned if treatment was required. The patient recovered (date not reported). Documents held by sender: None.
Age: 23.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Erythema, Papule, Thrombotic thrombocytopenic purpura, Treponema test negative
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 420652. A 23-year-old male patient with no concurrent illnesses and no medical history, had received the following vaccination on 27 January 2011: ACAM2000 (lot number not reported, route unknown), and 11 days later developed bilaterally on the hand and elbow several 1-2 mm coalescing erythematosus papules with (+) ITP (idiopathic thrombocytopenic purpura, coded by VAERS as: thrombotic thrombocytopenic purpura). Laboratory data: Treponema test negative. It was not mentioned if treatment was required. Use of other medications and prior vaccinations were not mentioned. The patient recovered (date not reported). Documents held by sender: None.
Age: 23.0
Sex: M
Vaccine: SMALL, SMALL
Symptoms: Erythema, Idiopathic thrombocytopenic purpura, Papule, Treponema test negative
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 420652. A 23-year-old male patient with no concurrent illnesses and no medical history, had received the following vaccination on 27 January 2011: ACAM2000 (lot number not reported, route unknown), and 11 days later developed bilaterally on the hand and elbow several 1-2 mm coalescing erythematosus papules with (+) ITP (idiopathic thrombocytopenic purpura, coded by VAERS as: thrombotic thrombocytopenic purpura). Laboratory data: Treponema test negative. It was not mentioned if treatment was required. Use of other medications and prior vaccinations were not mentioned. The patient recovered (date not reported). Documents held by sender: None.
Age: 24.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Erythema, Papule, Thrombotic thrombocytopenic purpura, Treponema test negative
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 420653. A 24-year-old female patient received the following vaccination on 27 January 2011: ACAM2000 (sanofi pasteur lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient had no medical history, no current illnesses and took no other medications. On 06 February 2011, the patient had developed on bilateral hand, elbow and chest several 1-2 mm coalescing erythematous papules with positive (+) thrombotic thrombocytopenic purpura (TTP). The patient had a negative treponema test. The outcome was reported as recovered. Documents held by sender: None.
Age: 24.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Rash papular, Thrombotic thrombocytopenic purpura, Treponema test negative
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 420653. A 24-year-old female patient received the following vaccination on 27 January 2011: ACAM2000 (sanofi pasteur lot number not reported). Although the manufacturer was reported as unknown in this case, ACAM2000 was the only licensed smallpox vaccine at the time of the patient's vaccination. The patient had no medical history, no current illnesses and took no other medications. On 06 February 2011, the patient had developed on bilateral hand, elbow and chest several 1-2 mm coalescing erythematous papules with positive (+) thrombotic thrombocytopenic purpura (TTP). The patient had a negative treponema test. The outcome was reported as recovered. Documents held by sender: None.
Age: 20.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Blister, Pain, Pruritus
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 420763. A 20-year-old female patient received the following vaccination on 16 March 2011: ACAM2000 (lot number VV04003A). The patient had no medical history and had no current illnesses. On 28 March 2011, approximately 2 weeks after vaccination, the patient experienced small fluid filled, itchy painful blisters all over body. The patient was given steroids and antihistamines at a civilian hospital. The treatment helped for a little while but the condition did not resolve. On 04 April 2011, the patient was given triamcinolone cream. She was seen again on 07 April 2011 and given a prescription for MOTRIN 800 milligrams (mg), PERCOCET 325 mg, clindamycin, BACTROBAN and ATARAX. The patient was also put on 2 weeks convalescent leave. The outcome was reported as unknown. Documents held by sender: None.
Age: 20.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Activities of daily living impaired, Blister, Pain, Pruritus
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 420763. A 20-year-old female patient received the following vaccination on 16 March 2011: ACAM2000 (lot number VV04003A). The patient had no medical history and had no current illnesses. On 28 March 2011, approximately 2 weeks after vaccination, the patient experienced small fluid filled, itchy painful blisters all over body. The patient was given steroids and antihistamines at a civilian hospital. The treatment helped for a little while but the condition did not resolve. On 04 April 2011, the patient was given triamcinolone cream. She was seen again on 07 April 2011 and given a prescription for MOTRIN 800 milligrams (mg), PERCOCET 325 mg, clindamycin, BACTROBAN and ATARAX. The patient was also put on 2 weeks convalescent leave. The outcome was reported as unknown. Documents held by sender: None.
Age: 26.0
Sex: M
Vaccine: SMALL
Symptoms: Chest pain, Electrocardiogram ST segment elevation, Troponin I increased
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 420793. A 26-year-old male patient, with a history of tobacco use, received a right arm injection of ACAM2000 (lot number VV04003A) on 22 March 2011. On 01 April 2011, 10 days post-vaccination, he experienced an onset of chest pain which he attributed to smoking. However, after 3 days of tobacco cessation the chest pain continued, and the patient presented to the urgent care clinic on 04 April 2011. Laboratory investigations revealed elevated troponin I and diffuse ST elevation on ECG. The patient was hospitalized, and the event was ongoing at the time of the report. Documents held by sender: None.
Age: 18.0
Sex: M
Vaccine: ANTH, SMALL, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Blood creatine phosphokinase MB increased, Chest discomfort, Dyspnoea, Intensive care, Troponin increased
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 420911. An 18-year-old male patient received the following vaccinations on 31 March 2011: ACAM2000 (lot number VV04-003-A), and BIOTHRAX (lot number FAV265). On 12 April 2011, 12 days post vaccination, the patient reported to medical with complaints of chest discomfort and shortness of breath. He was referred to the emergency room and subsequently hospitalized and admitted to ICU (intensive care unit). Laboratory test results included elevated CKMB and Troponin. At the time of vaccination, the patient had no current illness and no past history. In addition to hospitalization, seriousness criteria also listed the reported events as life threatening. Outcome was not reported. Documents held by sender: none.
Age: 18.0
Sex: M
Vaccine: ANTH, SMALL, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Echocardiogram normal, Electrocardiogram ST segment elevation, Electrocardiogram abnormal, Myopericarditis, Nuclear magnetic resonance imaging
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 420911. An 18-year-old male patient received the following vaccinations on 31 March 2011: ACAM2000 (lot number VV04-003-A), and BIOTHRAX (lot number FAV265). On 12 April 2011, 12 days post vaccination, the patient reported to medical with complaints of chest discomfort and shortness of breath. He was referred to the emergency room and subsequently hospitalized and admitted to ICU (intensive care unit). Laboratory test results included elevated CKMB and Troponin. At the time of vaccination, the patient had no current illness and no past history. In addition to hospitalization, seriousness criteria also listed the reported events as life threatening. Outcome was not reported. Documents held by sender: none.
Age: 18.0
Sex: M
Vaccine: ANTH, SMALL, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Troponin increased
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 420911. An 18-year-old male patient received the following vaccinations on 31 March 2011: ACAM2000 (lot number VV04-003-A), and BIOTHRAX (lot number FAV265). On 12 April 2011, 12 days post vaccination, the patient reported to medical with complaints of chest discomfort and shortness of breath. He was referred to the emergency room and subsequently hospitalized and admitted to ICU (intensive care unit). Laboratory test results included elevated CKMB and Troponin. At the time of vaccination, the patient had no current illness and no past history. In addition to hospitalization, seriousness criteria also listed the reported events as life threatening. Outcome was not reported. Documents held by sender: none.
Age: 18.0
Sex: M
Vaccine: ANTH, SMALL, SMALL, ANTH, SMALL, ANTH, SMALL
Symptoms: Echocardiogram abnormal, Electrocardiogram abnormal, Nuclear magnetic resonance imaging normal, Pericarditis, Troponin I increased
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 420911. An 18-year-old male patient received the following vaccinations on 31 March 2011: ACAM2000 (lot number VV04-003-A), and BIOTHRAX (lot number FAV265). On 12 April 2011, 12 days post vaccination, the patient reported to medical with complaints of chest discomfort and shortness of breath. He was referred to the emergency room and subsequently hospitalized and admitted to ICU (intensive care unit). Laboratory test results included elevated CKMB and Troponin. At the time of vaccination, the patient had no current illness and no past history. In addition to hospitalization, seriousness criteria also listed the reported events as life threatening. Outcome was not reported. Documents held by sender: none.
Age: 20.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Pruritus, Skin mass
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 420965. A 20-year-old female patient with no concurrent illnesses, no medical history, and no use of other medications, had received the following vaccinations on 22 March 2010: ACAM2000 (lot number VV04-003A), TYPHIM VI (lot number B1026), and BIOTHRAX (lot number FAV204). Thirty-seven days later, the patient developed a raised pruritic nodule that continued one year later. No laboratory data had been performed. Treatment provided, and prior vaccinations were not mentioned. The patient had not recovered. Coding used by VAERS: pruritus, skin mass. Documents held by sender: None.
Age: 20.0
Sex: F
Vaccine: ANTH, SMALL, TYP, ANTH, SMALL, TYP
Symptoms: Nodule, Pruritus
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 420965. A 20-year-old female patient with no concurrent illnesses, no medical history, and no use of other medications, had received the following vaccinations on 22 March 2010: ACAM2000 (lot number VV04-003A), TYPHIM VI (lot number B1026), and BIOTHRAX (lot number FAV204). Thirty-seven days later, the patient developed a raised pruritic nodule that continued one year later. No laboratory data had been performed. Treatment provided, and prior vaccinations were not mentioned. The patient had not recovered. Coding used by VAERS: pruritus, skin mass. Documents held by sender: None.
Age: 28.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Erythema, Formication, Injection site pruritus, Paraesthesia, Rash
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 421186. A 28-year-old female patient, with a history of mild seasonal allergies, received the following vaccination on 05 April 2011: ACAM2000 (lot number VV04003A). The patient's concomitant medication was reported as PROMETRIUM. On 13 April 2011, the patient felt her "skin crawling" and itching over left upper arm at vaccination site extending from near shoulder to elbow. She discovered a rash forming. On 14 April 2011, she developed maculopapular lesions 28 cm by 25 cm, florid red, and non-pustular. The lesion itself was 1 cm by 1 cm (vaccinia site). On 15 April 2011, the patient was seen at the clinic for right cheek tingling and right side of mouth drooping (slight). She required an Emergency visit. The patient was treated with ibuprofen 400 (units not provided) every six hours, ZYRTEC every morning, and BENADRYL 50 milligrams at bedtime (HS). The patient was to return to the clinic on 18 April 2011 at 8:00 AM. The outcome was reported as recovered. Documents held by sender: None.
Age: 28.0
Sex: F
Vaccine: SMALL, SMALL
Symptoms: Rash maculo-papular, Skin lesion, VIIth nerve paralysis
Clinical narrative: This case was received on 23 June 2011 via a third party query tool search on the VAERS database, under reference number 421186. A 28-year-old female patient, with a history of mild seasonal allergies, received the following vaccination on 05 April 2011: ACAM2000 (lot number VV04003A). The patient's concomitant medication was reported as PROMETRIUM. On 13 April 2011, the patient felt her "skin crawling" and itching over left upper arm at vaccination site extending from near shoulder to elbow. She discovered a rash forming. On 14 April 2011, she developed maculopapular lesions 28 cm by 25 cm, florid red, and non-pustular. The lesion itself was 1 cm by 1 cm (vaccinia site). On 15 April 2011, the patient was seen at the clinic for right cheek tingling and right side of mouth drooping (slight). She required an Emergency visit. The patient was treated with ibuprofen 400 (units not provided) every six hours, ZYRTEC every morning, and BENADRYL 50 milligrams at bedtime (HS). The patient was to return to the clinic on 18 April 2011 at 8:00 AM. The outcome was reported as recovered. Documents held by sender: None.